ხუთშაბათი, აპრილი 16, 2026
- Advertisement -
Google search engine
Global Ingredient Risk Index Metabolic

Beetroot Powder

Beta vulgaris (beet root, standardized nitrate)

Also known as: beet root powder, beetroot extract, dietary nitrate, beet juice powder

LOW RISK 2.0/10 How?

This ingredient is classified as unclassified risk (GIRI score: 2.0/10).

02

Safety Profile

Known Safety Concerns

  • Beeturia (benign red urine/stool) -- common
  • High oxalate content -- caution in kidney stone history
  • May lower blood pressure -- caution in hypotension
  • Antibacterial mouthwash negates effect

Contraindications

  • Beeturia (benign red urine/stool) -- common
  • High oxalate content -- caution in kidney stone history
═══════════════════════════════════════════════════════════════════════ -->
03

Interactions

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
04

Evidence and Scientific Findings

Overview

Ingredient Overview

Beetroot powder is standardized for dietary nitrate content, converted to nitric oxide via the enterosalivary pathway. Well-evidenced for blood pressure reduction and athletic endurance. Use of antibacterial mouthwash negates effect.

Classification

Biological and Chemical Classification

Scientific Name
Beta vulgaris (beet root, standardized nitrate)
Mechanism

Mechanism of Action

Information not yet available for this ingredient profile.

Clinical Evidence

Clinical Evidence of Effectiveness

Information not yet available for this ingredient profile.

Pharmacokinetics

Pharmacokinetics

Information not yet available for this ingredient profile.

Dosage

Recommended Dosage

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
05

SETI — Scientific Evidence Transparency Index

SETI Score 50/100
Risk Level High risk
Scientific Confidence Low
Evidence Strength Limited
Key Benefit Metabolic
Key Safety Concern Beeturia (benign red urine/stool) -- common
Evidence Reviewed 10 PubMed studies
Scientific Confidence Low
Based on study quality, consistency, and recency

Executive Summary — Ingredient Assessment

SETI Score 50/100
Risk Level High risk
Evidence Strength Limited
Main Benefit Metabolic
Main Safety Concern Beeturia (benign red urine/stool) -- common
Ingredient Beetroot Powder
Scientific name Beta vulgaris (beet root, standardized nitrate)
Scientific Evidence Overview
  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or RCT)
  • Main clinical benefit observed: Metabolic
  • Evidence consistency: High consistency across studies (100%)
Safety Signals
  • Beeturia (benign red urine/stool) -- common
  • High oxalate content -- caution in kidney stone history
  • May lower blood pressure -- caution in hypotension
  • Antibacterial mouthwash negates effect
Evidence Strength Limited
Final Scientific Assessment

The available scientific evidence for Beetroot Powder indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.

Ingredient Beetroot Powder
Evidence reviewed 10 peer-reviewed studies (last 10 years)
Scientific name Beta vulgaris (beet root, standardized nitrate)
50 /100

Total SETI Score

High risk
Evidence quality 10/40
Evidence consistency 20/20
Safety signals 0/20
Study recency 10/10
Evidence transparency 10/10

Evidence Summary

  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or systematic review)
  • 0 studies identified benefits or no safety concern (GREEN)
  • 10 studies reported limited or advisory safety evidence (YELLOW)

Evidence Policy

Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.

Last updated: 25 მარ 2026, 23:16

Evidence Distribution

10 Other / unclassified
  1. Observational / other LOW evidence YELLOW
    Impact of colostrum-derived whey and beetroot powder on the nutritional, rheological and sensory characteristics of set-type yogurt. ↗
    Journal J Food Sci Technol
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Mehra R et al.. Impact of colostrum-derived whey and beetroot powder on the nutritional, rheological and sensory characteristics of set-type yogurt.. J Food Sci Technol. 2026. PMID:41737702.
  2. Observational / other LOW evidence YELLOW
    The dose-response effects of nitrate-rich beetroot ingestion on cardiovascular and endothelial function: a randomised controlled trial. ↗
    Journal Food Funct
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    McLellan AG et al.. The dose-response effects of nitrate-rich beetroot ingestion on cardiovascular and endothelial function: a randomised controlled trial.. Food Funct. 2026. PMID:41704173.
  3. Observational / other LOW evidence YELLOW
    Beetroot Powder as Natural Colorant in Fresh Pork Sausages: Impacts on Consumer Liking, Emotional Responses, and Identification of Purchasing Drivers. ↗
    Journal Foods
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Willig R et al.. Beetroot Powder as Natural Colorant in Fresh Pork Sausages: Impacts on Consumer Liking, Emotional Responses, and Identification of Purchasing Drivers.. Foods. 2025. PMID:41227684.
  4. Observational / other LOW evidence YELLOW
    Formulations of novel microbial medium from beetroot powder: a sustainable substitute for commercial Man-de-Rogosa Sharp agar (MRS) in cultivating lactic acid bacteria. ↗
    Journal World J Microbiol Biotechnol
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Oussama B et al.. Formulations of novel microbial medium from beetroot powder: a sustainable substitute for commercial Man-de-Rogosa Sharp agar (MRS) in cultivating lactic acid bacteria.. World J Microbiol Biotechnol. 2025. PMID:41075044.
  5. Observational / other LOW evidence YELLOW
    Acute effects of beetroot juice vs. creatine supplementation on maximal strength, autonomic regulation, and muscle oxygenation during incremental resistance exercise. ↗
    Journal Biol Sport
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Salem A et al.. Acute effects of beetroot juice vs. creatine supplementation on maximal strength, autonomic regulation, and muscle oxygenation during incremental resistance exercise.. Biol Sport. 2025. PMID:41048226.
  6. Observational / other LOW evidence YELLOW
    Comparative Assessment of Matrix Integration Dynamics Between Beetroot Powder and Paste in Wheat-Based Cupcake Formulations. ↗
    Journal Food Sci Nutr
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Agyei-Poku B et al.. Comparative Assessment of Matrix Integration Dynamics Between Beetroot Powder and Paste in Wheat-Based Cupcake Formulations.. Food Sci Nutr. 2025. PMID:40927045.
  7. Observational / other LOW evidence YELLOW
    Red Beetroot Skin Powder Addition as a Multifunctional Ingredient in Nougat. ↗
    Journal Antioxidants (Basel)
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Constantin OE et al.. Red Beetroot Skin Powder Addition as a Multifunctional Ingredient in Nougat.. Antioxidants (Basel). 2025. PMID:40563310.
  8. Observational / other LOW evidence YELLOW
    Low Glycemic Index Biscuits Enriched with Beetroot Powder as a Source of Betaine and Mineral Nutrients. ↗
    Journal Foods
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Mitrevski J et al.. Low Glycemic Index Biscuits Enriched with Beetroot Powder as a Source of Betaine and Mineral Nutrients.. Foods. 2025. PMID:40077517.
  9. Observational / other LOW evidence YELLOW
    An assessment of laboratory changes during autologous whole blood transfusion training: A prospective, observational study. ↗
    Journal Transfusion
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Schauer SG et al.. An assessment of laboratory changes during autologous whole blood transfusion training: A prospective, observational study.. Transfusion. 2025. PMID:40021807.
  10. Observational / other LOW evidence YELLOW
    Enterotype-Specific Effects of Red Beetroot (Beta vulgaris L.) Powder and Betanin on Human Gut Microbiota: A Preliminary Study Based on In Vitro… ↗
    Journal Life (Basel)
    Year 2024
    Study type Observational / other
    Evidence strength LOW evidence
    Ko GP et al.. Enterotype-Specific Effects of Red Beetroot (Beta vulgaris L.) Powder and Betanin on Human Gut Microbiota: A Preliminary Study Based on In Vitro Fecal Fermentation Model.. Life (Basel). 2024. PMID:39598189.
═══════════════════════════════════════════════════════════════════════ -->
06

Score Transparency

Q × L × D × S × 10 = 2.0 / 10

The GIRI Score is the product of four independently computed evidence components, each normalised to 0–1, then scaled to 0–10. Every component is derived exclusively from peer-reviewed references and regulatory data — no editorial judgement is applied.

Q
Evidence Quantity 0 / 10
0%

0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.

Method: Q = number of approved references ÷ 10 (capped at 1.0)

L
Evidence Quality 5 / 10
50%

Limited — mostly case reports or animal studies

Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.

D
Evidence Direction 5 / 10
Benefit
Risk
50%

Mixed or neutral — roughly equal benefit and risk signals

Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.

S
Safety Signals 5 / 10
50%

One or more monitoring-level safety signals active

Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.

0Q × 5L × 5D × 5S = 2.0 / 10

Final GIRI Score for Beetroot Powder. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Full methodology & data sources

The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.

  • References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
  • Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
  • Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
  • Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
07

Risk Level Classification

LOW RISK 2.0/10

Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.

LOW
0–3.0
MODERATE
3.0–5.5
HIGH
5.5–7.5
CRITICAL
7.5–10
2.0

The score pin shows exactly where this ingredient falls on the fixed risk scale.

What drove the Low classification for Beetroot Powder

GIRI Score 2.0 / 10

A score of 2.0 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Evidence Quantity (Q) 0 / 10 refs

0 approved references.

Evidence Quality (L) 50%

Limited — mostly case reports or animal studies (Level 4–5).

Evidence Direction (D) 50% toward risk

Neutral or mixed — benefit and risk signals roughly balanced.

Safety Signals (S) 0 active signals

No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.

Regulatory Status No restrictions found

No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).

How are the Low / Moderate / High / Critical thresholds defined?

The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:

LevelScoreMeaning
LOW0.0 – 2.9Sparse or predominantly beneficial evidence. No active safety alerts.
MODERATE3.0 – 5.4Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups.
HIGH5.5 – 7.4Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended.
CRITICAL7.5 – 10Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision.

Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.